Clin2
NCT07220265Possibly a fitRecruiting

PKU carriers: How high phenylalanine affects the brain

Carrier of PhenylketonuriaHealthy

Part of Brain & nervous system, Genetic & congenital clinical trials.

This study looks at how carrying one copy of the PKU gene might affect thinking and brain health in adults. It will help researchers understand if mild changes in a substance called phenylalanine can impact memory, focus, and brain scans.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
36 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You are a parent, sibling, or confirmed carrier of the PKU gene (meaning you have one copy but not the disease).
  • OR you are in the non-carrier group and have no PKU in your family.
  • Your body mass index (BMI) is 30 or less.
  • You do not smoke or use nicotine products.
  • You do not have a metal implant, pacemaker, or other MRI safety concern, and you are not pregnant or planning pregnancy.
  • You do not have a major brain condition like multiple sclerosis, severe head injury, or Parkinson's disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06337864Recruiting
Large neutral amino acids for adults with classical PKU

This study tests whether a specific mix of large neutral amino acids (LNAAs) can help adults with classical PKU by lowering phenylalanine levels in the brain. It includes an MRI and PET scan to see how the treatment affects brain activity.

Copenhagen
NCT06969209Recruiting
Brain aging in adults with PKU

This study looks at how the brain ages in adults with PKU. It uses an MRI scan to compare brain changes between people with PKU and healthy volunteers.

Bern
NCT05128149Recruiting
PKU care guidelines and how they affect daily well-being

This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.

Zurich
NCT07406009Not yet recruiting
Psychosocial functioning in adults with phenylketonuria

This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) cope with daily life, emotions, and relationships, with input from a relative who lives with them. The goal is to better understand the challenges so care can be improved.

NCT07825883Recruiting
Home blood tests for phenylketonuria management

This study looks at whether checking phenylalanine levels at home more often helps people with classic PKU keep their levels in a healthy range. It may help you manage your diet and treatment more effectively.

Krakow
NCT07728032Recruiting
How diet and medicine affect gut health in PKU children

This study looks at how a phenylalanine-restricted diet or certain PKU medicines affect gut health in children with PKU. It also includes healthy siblings or household members as a comparison group.

Birmingham, Birmingham

Hear when a new Carrier of Phenylketonuria trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.